129 results
Page 2 of 7
425
EX-2.1
9ezs512 ziurur2r52
8 Nov 18
Business combination disclosure
6:41am
8-K
EX-2.1
pxicy35tpfrd
8 Nov 18
BioTime and ASTERIAS BIOTHERAPEUTICS enter into definitive merger agreement TO CREATE leading cell therapy company
6:41am
424B5
57v6j 2xulmmp17
13 Oct 17
Prospectus supplement for primary offering
12:00am
424B5
32qyj1 kskvoy
12 Oct 17
Prospectus supplement for primary offering
12:00am
424B5
va8s9f5cky74duza0f1r
14 Sep 15
Prospectus supplement for primary offering
12:00am
8-K
EX-99.1
jpg pvb9jus7
3 Oct 14
Regulation FD Disclosure
12:00am
424B5
vnvnaew
3 Oct 14
Prospectus supplement for primary offering
12:00am
8-K
EX-99.1
6i0x0qq dk8
14 Jul 14
BioTime Announces Issuance of 14 Patents in the Fields of Regenerative Medicine, and Cancer Diagnosis and Therapy
12:00am